Biotech

Biotech & Healthcare News

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech

Top news of the week: 28.12.2021.

#healthtech
#EdenHealth
#Personalizedmedicine
#Synthego
#unicorns
#startup
#GlobalData
#Genomics
#Earlens
#Digitaltherapeutics

Healthcare

@Healthcare_GD shared
On Dec 23, 2021
#GlobalData predicts future #healthtech #unicorns https://t.co/xnVjzvOtQ5 #Digitaltherapeutics #Earlens #EdenHealth #Genomics, #HumanAPI #Personalizedmedicine #pharma #precisionmedicine #startup #Synthego #UnivercellsTechnologies https://t.co/tzpAJyo7LN
Open
23 Dec 2021 GlobalData predicts future healthtech unicorns

23 Dec 2021 GlobalData predicts future healthtech unicorns

Healthcare startups are constantly seeking to embrace emerging technologies to improve efficiency, increase customer engagement, and remain competitive. Against this backdrop, the Unicorn ...

@emilylmullin shared
On Dec 22, 2021
RT @AP: The U.S. has authorized the first pill against COVID-19, a Pfizer drug that Americans can take at home to reduce the risk of hospitalization and death. The announcement comes as the U.S. braces for a wave of new infections from the omicron variant. https://t.co/9whaTANKOK
Open
Pfizer pill becomes 1st US-authorized home COVID treatment

Pfizer pill becomes 1st US-authorized home COVID treatment

WASHINGTON (AP) — U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of ...

@ldtimmerman shared
On Dec 21, 2021
Thinking about health data and how to make better use of it. Listen to the latest Long Run podcast with @vintweeta @a16z https://t.co/IYhhv1nX4v
Open
Physician-Scientist-Biotech VC: Vineeta Agarwala on The Long Run

Physician-Scientist-Biotech VC: Vineeta Agarwala on The Long Run

Today’s guest on The Long Run is Vineeta Agarwala. Vineeta is a general partner with Andreesen Horowitz’s bio fund. Vineeta has spent a lot of time on the front lines of an explosion in ...

@matthewherper shared
On Dec 22, 2021
RT @celinegounder: 1/ Why is it so hard 2 years into the pandemic to access rapid at-home COVID tests? Why are they still so expensive? with @PBS @NewsHour's @TheStephSy More from @KFF: https://t.co/wOfR9fcRCj & @ProPublica: https://t.co/2oSAz85vJy & @ArmAndaLegShow: https://t.co/lgsE8tQbGc https://t.co/L2845kbwvb
Open
Here’s Why Rapid COVID Tests Are So Expensive and Hard to Find

Here’s Why Rapid COVID Tests Are So Expensive and Hard to Find

Months-long silences. Mysterious rejections. Here’s what's behind the shortages of a critical tool for ending the pandemic.

@matthewherper shared
On Dec 21, 2021
RT @rickberke: Background as we await Elizabeth Holmes verdict: -- My interview with a protégée turned whistleblower who said Holmes should spend at least 5 years in prison. https://t.co/oL0ks4ai3V via @statnews -- My convo with @matthewherper about Holmes https://t.co/owMewfQfDp via @statnews
Open
From protégée to whistleblower: A former Theranos scientist says Elizabeth Holmes should ‘come forward and apologize’

From protégée to whistleblower: A former Theranos scientist says Elizabeth Holmes should ‘come forward and apologize’

Erika Cheung joined Theranos fresh out of college as a “starry-eyed’’ 22-year-old chemist and biologist. Seven months later, she blew the whistle.

Read more: Healthcare
weekly 28.12.2021
View archives
Back to home

Subscribe to Biotech - Biotech & Healthcare.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech - Biotech & Healthcare.
Privacy Policy

Sign up for the weekly Biotech - Biotech & Healthcare newsletter

Never again miss anything or anyone that matter in Biotech

Sign up and receive the Biotech - Biotech & Healthcare weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy